THE RELATION OF SLEEP RESPIRATION DISORDERS AND CARDIOVASCULAR RISK
https://doi.org/10.15829/1728-8800-2016-6-46-52
Abstract
Aim. To assess the relation of obstructive sleep apnea syndrome (OSAS) by the data of Berlin questionnaire and risk of fatal cardiovascular events. Material and methods. Totally, 275 persons studied (115 males, 160 females) age 25-64 y.o., with unknown cardiovascular complications, underwent structured interview. The risk of sleep-disordered breathing was assessed by Berlin questionnaire, cardiovascular risk — by SCORE. Anthropometric parameters were studied, as lipid profile, fasting glucose, uric acid, creatinine, C-reactive protein, adiponectin, leptin.
Results. The increased OSAS risk according to Berlin questionnaire was found in 7,3% of the studies. Most (90,0%) common was concomitance of the components of OSAS such as snoring/stops of respiration and cardiometabolic disorders. Males more frequently complained on snoring/ stops of breathing — 21,7% vs 6,3% (p=0,001), that determined higher general risk of OSAS among them comparing to women — 11,3% vs 4,4% (p=0,03). For males (1,7%) and females (3,1%) the complaints on daytime sleepiness were less common. Among those 40 y.o. and older the increased risk of OSAS was found in 9,8%, comparing to 1,2% younger than 40 y.o. (p=0,01). In higher OSAS risk there was higher total cholesterol — 6,10±0,18 vs 5,53±0,09 mM/L (p=0,05) and low density lipoproteides — 4,17±0,19 vs 3,59±0,08 mM/L (p=0,02); they were more often overweight — body mass index 31,73±1,19 vs 27,71±0,38 kg/m2 (p=0,001), and had higher systolic pressure — 134,89±4,96 vs 126,72±1,18 mmHg. (p=0,04) and diastolic pressure — 84,26±2,69 vs 78,55±0,80 mmHg (p=0,03). Respondents with higher risk of OSAS regardless the gender, did not differ by SCORE. While determine the specific combinations of OSAS components, there was no independent significance of snoring/respiration pauses and daytime sleepiness in the total cardiovascular risk by SCORE.
Conclusion. In the Russian population, higher OSAS risk is associated with the signs of metabolic syndrome. Berlin questionnaire does not reveal the subgroups of those who have OSAS risk together with cardiovascular risk.About the Authors
E. A. DubininaRussian Federation
L. S. Korostovtseva
Russian Federation
О. P. Rotar
Russian Federation
S. О. Kravchenko
Russian Federation
М. A. Boyarinova
Russian Federation
A. V. Orlov
Russian Federation
V. N. Solntsev
Russian Federation
Yu. V. Sviryaev
Russian Federation
А. N. Alyokhin
Russian Federation
A. О. Konradi
Russian Federation
References
1. Parati G, Lombardi C, Hedner J, et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respiratory J 2013; 41(3): 523-38.
2. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118(10): 1080-111.
3. Netzer N, Stoohs R, Netzer C, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131(7): 485-91.
4. Amra B, Nouranian E, Golshan M, et al. Validation of the persian version of berlin sleep questionnaire for diagnosing obstructive sleep apnea. Int J Prev Med 2013; 4(3): 334-9.
5. Bouloukaki I, Komninos ID, Mermigkis C, et al. Translation and validation of Berlin questionnaire in primary health care in Greece. BMC Pulm Med 2013; 3: 6.
6. Chung F, Yegneswaran B, Liao P, et al. Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients. Anesthesiology 2008; 108(5): 822-30.
7. Shalnova SA, Kontsevaia AV, Karpov IuA, et al. Epidemiological monitoring as a tool for planning programs for the prevention of chronic noncommunicable diseases and their risk factors. Profilakticheskaia meditsina 2012; 15(6): 64-8. Russian (Шальнова С. А., Концевая А. В., Карпов Ю. А. и др. Эпидемиологический мониторинг как инструмент планирования программ профилактики хронических неинфекционных заболеваний и их факторов риска. Профилактическая медицина 2012; 15(6): 64-8).
8. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-70.
9. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. The New England J Med 1993; 328(17):1230-5.
10. Mazzuca E, Battaglia S, Marrone O, et al. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J of Sleep Research 2014; 23(1):13-21.
11. Luo J, Huang R, Zhong X, et al. STOP-Bang questionnaire is superior to Epworth sleepiness scales, Berlin questionnaire, and STOP questionnaire in screening obstructive sleep apnea hypopnea syndrome patients. Chin Med J 2014; 127(17): 3065-70.
12. Li T-P, Feng Y, Li D-Q, et al. A Nomogram for Predicting the Likelihood of Obstructive Sleep Apnea to Reduce the Unnecessary Polysomnography Examinations. Chinese Medical J 2015; 128(16): 2134.
13. Forni Ogna V, Ogna A, Pruijm M, et al. Prevalence and Diagnostic Approach to Sleep Apnea in Hemodialysis Patients: A Population Study. BioMed Research International 2015; 2015: 1-9.
14. Ye L, Pien GW, Ratcliffe SJ, et al. The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 2014; 44(6):1600-7.
15. Bixler EO, Vgontzas AN, Lin HM, et al. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005; 90: 4510-5.
16. Ye L, Pien GW, Ratcliffe SJ, et al. The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 2014; 44(6): 1600-7.
Review
For citations:
Dubinina E.A., Korostovtseva L.S., Rotar О.P., Kravchenko S.О., Boyarinova М.A., Orlov A.V., Solntsev V.N., Sviryaev Yu.V., Alyokhin А.N., Konradi A.О. THE RELATION OF SLEEP RESPIRATION DISORDERS AND CARDIOVASCULAR RISK. Cardiovascular Therapy and Prevention. 2016;15(6):46-52. (In Russ.) https://doi.org/10.15829/1728-8800-2016-6-46-52